These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 23996116)

  • 1. MRI differentiation of cardiomyopathy showing left ventricular hypertrophy and heart failure: differentiation between cardiac amyloidosis, hypertrophic cardiomyopathy, and hypertensive heart disease.
    Takeda M; Amano Y; Tachi M; Tani H; Mizuno K; Kumita S
    Jpn J Radiol; 2013 Oct; 31(10):693-700. PubMed ID: 23996116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertensive heart disease versus hypertrophic cardiomyopathy: multi-parametric cardiovascular magnetic resonance discriminators when end-diastolic wall thickness ≥ 15 mm.
    Rodrigues JC; Rohan S; Ghosh Dastidar A; Harries I; Lawton CB; Ratcliffe LE; Burchell AE; Hart EC; Hamilton MC; Paton JF; Nightingale AK; Manghat NE
    Eur Radiol; 2017 Mar; 27(3):1125-1135. PubMed ID: 27368925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypertrophic cardiomyopathy with dilatation of the left ventricle and congestive heart failure: comparison with postmyocarditis cardiomegaly and hypertensive heart failure].
    Kawanishi H; Yokota Y; Hayakawa M; Kaku K; Kumaki T; Matsumoto K; Fujitani K; Ito Y; Inoh T; Fukuzaki H
    J Cardiogr; 1983 Sep; 13(3):537-50. PubMed ID: 6235295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Native T1 mapping for the diagnosis of cardiac amyloidosis in patients with left ventricular hypertrophy.
    Lavall D; Vosshage NH; Geßner R; Stöbe S; Ebel S; Denecke T; Hagendorff A; Laufs U
    Clin Res Cardiol; 2023 Mar; 112(3):334-342. PubMed ID: 35355115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-parametric assessment of left ventricular hypertrophy using late gadolinium enhancement, T1 mapping and strain-encoded cardiovascular magnetic resonance.
    Giusca S; Steen H; Montenbruck M; Patel AR; Pieske B; Erley J; Kelle S; Korosoglou G
    J Cardiovasc Magn Reson; 2021 Jul; 23(1):92. PubMed ID: 34247623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Integrated Algorithm for Differentiating Hypertrophic Cardiomyopathy From Hypertensive Heart Disease.
    Kong LC; Wu LM; Wang Z; Liu C; He B
    J Magn Reson Imaging; 2023 Oct; 58(4):1084-1097. PubMed ID: 36688928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simple criteria for differentiation of Fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy.
    Hoigné P; Attenhofer Jost CH; Duru F; Oechslin EN; Seifert B; Widmer U; Frischknecht B; Jenni R
    Int J Cardiol; 2006 Aug; 111(3):413-22. PubMed ID: 16307805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T1 Mapping and Extracellular Volume in Cardiomyopathy Showing Left Ventricular Hypertrophy: Differentiation Between Hypertrophic Cardiomyopathy and Hypertensive Heart Disease.
    Liang L; Wang X; Yu Y; Zhang Y; Liu J; Chen M; Zhang L; Jiang T
    Int J Gen Med; 2022; 15():4163-4173. PubMed ID: 35465304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of assessing left ventricular longitudinal systolic peak strain in differential diagnosis of primary cardiac amyloidosis from hypertrophic cardiomyopathy].
    Zhang L; Wang Y; Cheng L; Wang J; Zhou X; Liu M; Zhang W; Zhang M; Zhang B; Zhi G
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 May; 34(5):609-16. PubMed ID: 24849421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular structure and diastolic function by cardiac magnetic resonance imaging in hypertrophic cardiomyopathy.
    Chacko BR; Karur GR; Connelly KA; Yan RT; Kirpalani A; Wald R; Jimenez-Juan L; Jacob JR; Deva DP; Yan AT
    Indian Heart J; 2018; 70(1):75-81. PubMed ID: 29455792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertrophic cardiomyopathy and left ventricular hypertrophy in hypertensive heart disease with mildly reduced or preserved ejection fraction: insight from altered mechanics and native T1 mapping.
    Wu LM; An DL; Yao QY; Ou YZ; Lu Q; Jiang M; Xu JR
    Clin Radiol; 2017 Oct; 72(10):835-843. PubMed ID: 28552325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling.
    Rudolph A; Abdel-Aty H; Bohl S; Boyé P; Zagrosek A; Dietz R; Schulz-Menger J
    J Am Coll Cardiol; 2009 Jan; 53(3):284-91. PubMed ID: 19147047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiomic Analysis of Myocardial Native T
    Neisius U; El-Rewaidy H; Nakamori S; Rodriguez J; Manning WJ; Nezafat R
    JACC Cardiovasc Imaging; 2019 Oct; 12(10):1946-1954. PubMed ID: 30660549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial contraction fraction derived from cardiovascular magnetic resonance cine images-reference values and performance in patients with heart failure and left ventricular hypertrophy.
    Arenja N; Fritz T; Andre F; Riffel JH; Aus dem Siepen F; Ochs M; Paffhausen J; Hegenbart U; Schönland S; Müller-Hennessen M; Giannitsis E; Kristen AV; Katus HA; Friedrich MG; Buss SJ
    Eur Heart J Cardiovasc Imaging; 2017 Dec; 18(12):1414-1422. PubMed ID: 28165128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Late gadolinium enhancement and T1 mapping for the diagnosis of cardiac amyloidosis].
    Cui Q; Yu J; Shen W
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Dec; 31(12):1538-1541. PubMed ID: 32029045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
    Ho CY; Abbasi SA; Neilan TG; Shah RV; Chen Y; Heydari B; Cirino AL; Lakdawala NK; Orav EJ; González A; López B; Díez J; Jerosch-Herold M; Kwong RY
    Circ Cardiovasc Imaging; 2013 May; 6(3):415-22. PubMed ID: 23549607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.
    Urbano-Moral JA; Rowin EJ; Maron MS; Crean A; Pandian NG
    Circ Cardiovasc Imaging; 2014 Jan; 7(1):11-9. PubMed ID: 24275954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tricuspid annular motion velocity as a differentiation index of hypertrophic cardiomyopathy from hypertensive heart disease.
    Hayashi S; Yamada H; Nishio S; Hotchi J; Bando M; Takagawa Y; Saijo Y; Hirata Y; Sata M
    J Cardiol; 2015 Jun; 65(6):519-25. PubMed ID: 25199979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The differences in left ventricular torsional behavior between patients with hypertrophic cardiomyopathy and hypertensive heart disease.
    Saito M; Okayama H; Yoshii T; Hiasa G; Sumimoto T; Inaba S; Nishimura K; Inoue K; Ogimoto A; Ohtsuka T; Funada J; Shigematsu Y; Higaki J
    Int J Cardiol; 2011 Aug; 150(3):301-6. PubMed ID: 20471702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular magnetic resonance feature tracking strain analysis for discrimination between hypertensive heart disease and hypertrophic cardiomyopathy.
    Neisius U; Myerson L; Fahmy AS; Nakamori S; El-Rewaidy H; Joshi G; Duan C; Manning WJ; Nezafat R
    PLoS One; 2019; 14(8):e0221061. PubMed ID: 31433823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.